Daiichi Sankyo eyes newer cancer drugs to stave off rivals
Daiichi Sankyo will seek to maintain its edge over competitors in precision cancer therapies by pushing ahead with clinical trials of drug candidates being developed using new technology, a top executive has said. The drugmaker believes its next generation …